Quantum-Si IncorporatedQSI
About: Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Employees: 143
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
81% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 21
12% more funds holding
Funds holding: 120 [Q4 2024] → 134 (+14) [Q1 2025]
11% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 35
8.35% less ownership
Funds ownership: 43.71% [Q4 2024] → 35.36% (-8.35%) [Q1 2025]
22% less call options, than puts
Call options by funds: $1.48M | Put options by funds: $1.89M
52% less capital invested
Capital invested by funds: $145M [Q4 2024] → $69.2M (-$75.7M) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for QSI.
Financial journalist opinion
Based on 3 articles about QSI published over the past 30 days









